At a glance
ClinicalIndex Comparison RecordN/ACompleted· 344 enrolled
Drug / intervention
senofilcon A prototype +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Performance of Senofilcon A Investigational Lens
In Brief
A clinical study evaluating senofilcon A prototype and Dailies Total 1 for Visual Acuity. Completed, enrolled 344 participants across 19 sites.
Detailed Summary
This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartMar 2022
First PostedMar 2022
Primary CompletionMay 2022
TodayJul 2026
First PostedMar 29, 2022
Enrollment StartMar 21, 2022
Primary CompletionMay 25, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.3 years ago
Interventions
senofilcon A prototypedevice
Test
Dailies Total 1device
Control